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What is known about this topic?  
 Congenital diseases (e.g. cystic fibrosis) with high mortality or morbidity would benefit from 
an early intervention in the neonatal or fetal period. 
 Pig lungs share many anatomical, biochemical and physiological features with human lungs. 
What does this study add?  
 Minimally invasive fetoscopic tracheal delivery procedures have been developed for some 
large animal models, but not yet for pigs. 
 The model described allows therapeutics to be delivered in a translational animal species to 
treat diseases requiring early intervention.  
 
 
Abstract  
Objectives: The aim of this study was to assess the feasibility of fetal tracheal injection in the late-
gestational pig to target the airways.  
Methods: Following laparotomy and hysterotomy, fetoscopy was performed in pregnant sows to 
access the fetal trachea. Two volumes of fluospheres were injected (1 and 3 mL). Fluospheres 
distribution to the different lung lobes was investigated by microscopy. Possible fetal airway injury, 
caused by the surgical procedure or intratracheal injection, was investigated. Lung morphology and 
fetal lung volumes were calculated by micro computed tomography (µCT).  
Results: Intratracheal administration was successfully performed in 20/21 fetuses. Analysis by 
confocal microscopy demonstrated that 3 mL, and not 1 mL, most efficiently targeted all lung lobes. 
On high-resolution µCT, total airway volume was estimated at 2.9 mL, strengthening that 3 mL is 
appropriate to target all lung lobes. No procedural damage was evidenced in the lungs or trachea.  
Conclusions: Intratracheal injection of nanoparticles is feasible in the pregnant pig and does not 
cause procedural lung damage. Using an injection volume of 3 mL, all lung lobes were efficiently 
targeted. This nanoparticle delivery model to fetal airways opens perspectives for therapeutic 
interventions. 
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Introduction  
Advances in next-generation sequencing, non-invasive procedures to isolate fetal DNA from the 
maternal circulation as well as high resolution ultrasound have improved first trimester diagnosis of 
congenital conditions 1-3. Fetal intervention can be used to treat congenital or perinatal diseases with 
high mortality or morbidity if left untreated.  
Cystic Fibrosis (CF) is the most common life-threatening, monogenic disease in the Caucasian 
population, caused by mutations in CFTR, coding for the Cystic Fibrosis Transmembrane 
Conductance Regulator protein (CFTR), a chloride/bicarbonate channel regulating fluid transport 
across epithelia. Although much attention goes to personalized therapy by development of 
mutation-specific drugs 4, gene therapy remains an attractive option since it is applicable to all 
patients irrespective their specific mutation 5, 6.  
Patients with CF could benefit from an early intervention, starting in the neonatal or even fetal 
period as pathology in several organs is already apparent at birth 7. CF animal models have been 
generated in different species, i.e. mouse, rat, ferret and pig 8-12. Pig lungs share many anatomical, 
histological, biochemical and physiological features with human lungs 9. While CF pigs lack lung 
inflammation at birth, they show impaired mucociliary clearance which leads to a failure to eradicate 
bacteria 13. This leads to lung disease within the first few months of life. The relatively fast 
maturation rate and large number of offspring in a single sow allows fast progress in characterization 
of disease pathogenesis and treatment development in contrast to non-human primates, also used 
as a translational model for human diseases. The long life-span of pigs (10-15 years) offers 
advantages for evaluating long-term therapeutic efficacy of small molecules, gene therapy or 
engineered stem cells, and possible adverse effects that might only become apparent over time.  
Before the generation of the different large animal models for CF such as pig, wild-type (WT) sheep 
were regularly used for translational CF gene therapy studies 14, 15. Sheep have a similar lung size as 
humans, which allows the use of the same injection volume and application device for aerosol 
delivery to the lungs. Toxicity studies of non-viral vectors delivering hCFTR to sheep airways have 
demonstrated tolerability to the gene transfer agent as well as the presence of hCFTR mRNA in 
epithelial brushings or lung biopsies. The new large animal models for CF will in future allow not only 
the safety profile of the gene transfer agent to be evaluated, but additionally provide read-outs on 
the major hallmarks of CF airway disease. 
Previously, we demonstrated that direct intratracheal delivery of fluospheres and viral vectors to the 
lungs of fetal mice resulted in more efficient targeting of lung parenchyma compared to intra-
amniotic delivery 16, 17. An efficient delivery route becomes even more important when upscaling to a 
large animal model, e.g. pig. Minimally invasive fetoscopic endoluminal tracheal delivery procedures 
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have been developed by our group for several large animal models such as sheep 18-20 and non-
human primates 21. 
In this study, our aim was to establish a pig model for minimally invasive fetoscopic endoluminal 
tracheal injection of nanoparticles, including viral vectors, stem cells or small molecules. This model 
would not only be applicable to study therapeutic approaches for CF, but also for other genetic 
disorders such as surfactant deficiency 22. Additionally, iatrogenic conditions of the premature 
newborn such as bronchopulmonary dysplasia could benefit from transient overexpression of anti-
oxidative proteins to reduce oxidative damage 23.  
Materials and Methods 
The primary goal of this study was to assess the feasibility of fetoscopic intratracheal delivery of 
nanoparticles in pigs. Secondary goals were the evaluation of the efficacy of intratracheal injection 
and the potential acute procedural-related effects on lung morphometry.  
Animals Housing  
Two pregnant sows (Sus scrofa domesticus, Belgian Landrace) were used (1-2 years, 250 kg). Animals 
were housed in individual stables at the Zootechnical Institute (Lovenjoel, KU Leuven, Belgium). All 
procedures were approved by the Animal Care and Use Committee at KU Leuven (P235-2014).  
Experimental Design 
Following a 2 weeks acclimation period, each sow underwent surgery at gestational age 90 (F90, 114 
days for full gestation). By fetoscopic endoluminal tracheal injection, fluorescent molecules (anionic 
carboxylate-modified fluospheres, F8801, 100 nm, Molecular Probes, Leiden, The Netherlands) were 
delivered in two volumes: 1 and 3 mL. Non-injected fetuses were taken along as age-matched 
littermate controls. Piglets were harvested immediately post-surgery to collect lungs for further 
analysis. 
Preoperative and Operative Care 
Detailed protocols on the induction and maintenance of anesthesia are available in the online data 
supplement. Briefly, anesthesia was induced by intramuscular injection (0.1 mL/kg) of a mixture of 
zolazepam/tiletamine (Zoletil100-5 mL; Virbac s.a., Carros, France) and xylazin (Xyl-M 2%-25 mL; 
V.M.D.nv/sa, Arendonck, Belgium). Anesthesia was maintained by intravenous administration of 
ketamin (Nimatek, 100 mg/mL, Eurovet, Bladel, The Netherlands) at a constant rate perfusion of 6-
10 mL/h (50 mg/mL). Fentanyl (2 µg/kg) was administered IV at 1.5 h intervals to provide intra-
operative pain relief. Operated fetuses received an additional sedation mix IM into the biceps 
femoris (Fentanyl, 15 µg/kg; pancuronium (Pavulon), 0.4 mg/kg; Atropin, 0.1 mg/kg) at the beginning 
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of the injection procedure, also clinically used 24, to facilitate intratracheal injection by temporarily 
inhibiting breathing and swallowing reflexes and prevent bradycardia. After completion of surgery, 
anesthesia was stopped and T61 (0.3 mL/kg; Marion Roussel Hoechst, Brussels, Belgium) 
administered IV to the sow for euthanasia.  
Surgical procedure 
Detailed protocols on the surgical procedure are available in the online data supplement. In short, 
the sow was laid on the right flank after induction and general anesthesia (Fig. 1A). A 30 cm 
ventrolateral vertical skin incision was performed between the coxal tuber and the costal arch of the 
last rib. The fascia, external and internal abdominal oblique muscle and the peritoneum were 
subsequently opened. The uterus was partially elevated from the abdominal cavity. Next, gentle 
external pressure was applied to bring the fetal snout to a surgically accessible area away from the 
placenta and locate the best place for hysterostomy. Two sutures (3-0 Prolene, Johnson & Johnson 
Medical N.V, Diegem Belgium) were placed to fix chorion and amnion to the uterine wall at the 
height of the fetal snout (Fig. 1B). All layers of the uterine wall were opened by monopolar 
coagulation to generate a 1.5 cm incision. Amnion and chorion were sutured with two sutures to the 
uterine muscle using single stitches (3-0 Prolene). The fetal snout was held in place in front of the 
opening by the assisting surgeon while making sure that the mouth was submerged in amniotic fluid. 
Next, the fetoscopic instruments were inserted into the fetal mouth (Fig. 1C,D), i.e. a slightly bent 
10-Fr sheath (11540 KE Karl Storz, Tutlingen, Germany) with a connection for amnio-infusion and a 
1.3 mm fetoscope (11540 AA, Karl Storz). The fetoscope was connected to the light source and video 
recorder (20045001-DE, Tele Pack X, Karl Storz). Under constant amnio-infusion with pre-warmed 
(37 °C) Hartmann solution (B. Braun Melsungen AG, Melsungen, Germany), the endoscope was 
introduced into the fetal mouth and directed over the tongue along the midline by visualizing the 
raphe of the palate (Fig. 2A), to the pharynx, then to the larynx with the epiglottis as a landmark (Fig. 
2B), and finally through the arytenoid cartilage and vocal cords (Fig. 2C,D) to the trachea (Fig. 2E). 
The landmarks appeared different than in humans 24, e.g. a separate pouch was identified dorsal of 
the arytenoid cartilage being the pharyngeal diverticulum (Fig. 2C, arrow) and the tracheal bronchus 
was observed branching off the trachea (Fig. 2E, arrow).  The amnio-infusion was stopped after 
reaching the fetal trachea. Through an additional port of the fetoscopic sheath we first aspirated 
approximately 1.5 mL of tracheal fluid before injecting fluospheres (1 or 3 mL) into the lungs while 
keeping the fetoscope in place cranial to the tracheal bronchus (Figs. 1E, 2E,F). After injection, the 
fetoscope was withdrawn under visual control. The fetus was thereafter delivered through 
hysterotomy and a lethal dose of T61 (0.3 mL/kg) was immediately injected into the umbilical vein to 
prevent breathing movements while its mouth was submerged in amniotic fluid.  
  
 
This article is protected by copyright. All rights reserved. 
Macroscopic evaluation  
Fetal parameters were determined at F90 (Table 1) on euthanized fetuses as a reference for future 
comparison with diseased age-matched piglets (e.g. CF piglets). Detailed procedures can be found in 
the online data supplement. 
Determination of the optimal volume for intratracheal injection 
To determine the optimal volume for intratracheal injection, we randomly chose two different 
volumes 1 and 3 mL (n=10/volume), based on data from adult 25-30 kg Yorkshire pigs where a 10 mL 
volume of treated cells was intratracheally injected 25. Immediately post-surgery and T61 injection, 
the thoracic cavity was opened, the trachea ligated and the lungs removed from the body. Next, the  
lungs were fixed in 4% paraformaldehyde overnight at 4°C. Non-injected control fetuses were 
processed the same way. Samples were processed for cryosectioning as described previously 17. Each 
lung sample was dissected into seven segments (i.e. left cranial and caudal lobes; right cranial, 
middle, accessory and caudal lobes and trachea, Fig. 3A). Nuclei and actin filaments were stained 
with DAPI (1:2000, Sigma-Aldrich, Bornem, Belgium) and Alexa Fluor 488 phalloidin (1:200, 
Invitrogen, Merelbeke, Belgium). Confocal images were made using a LSM 510 Meta Multiphoton 
microscope with ZEN 2009 software (Carl Zeiss). The relative fluorescence intensity (ratio of red to 
blue fluorescence representing fluospheres and nuclear staining, respectively) was quantified using 
ImageJ.  
Histological examination of the lungs  
Detailed protocols on morphometry analysis of injected piglet lungs are available in the online data 
supplement. In short, the acute lung injury scoring system of the American Thorax Society was 
applied to the different lung segments (Fig. 3A) as described previously 26. Alterations of the fetal 
trachea were evaluated using a binomial scoring system as described before 27.  
Assessment of normal lung morphology and lung volumes of the fetal lung by µCT 
Although histology remains the current gold standard for lung morphometry, no three-dimensional 
information can be gained. This limitation makes a direct analysis of the complex 3D shapes of the 
small airways difficult. We therefore determined the morphological correlate of the hypothesized 
optimal volume for fetal intratracheal injection in the canalicular phase (F90) of lung development 
via µCT, a technique successfully used to study the small airways 28. As the fetal porcine lung has not 
been studied by µCT before, we additionally wanted to characterize normal morphology of a wild-
type pig fetus to allow future comparison with diseased fetal lungs, e.g. CF pigs. Technical details on 
µCT acquisition and analysis are given in the online data supplement. 
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Statistics 
SPSS (version 21, IBM Corporation, Armonk, US) was used. One-way ANOVA was performed and a p-
value < 0.05 considered significant. Data are presented as mean ± s.d. 
 
Results 
Feasibility of fetal intratracheal injection  
Twenty-one of 32 fetal pigs underwent fetoscopy. All fetuses survived till harvesting (32/32). In the 
first sow we performed fetoscopy in 10 of 15 fetuses; in the second in 11 out of 17. Tracheoscopy 
was performed in all but one piglet in the first sow, in which iatrogenic tissue damage precluded the 
successful entrance of the trachea with the fetoscope. More specifically, the fetoscope was 
unintentionally inserted into the pharyngeal diverticulum which led to a false route. Therefore 
tracheoscopy was successful in 20 of 21 attempts and in total 20 of the 32 fetuses underwent 
tracheoscopy. The lungs of the remaining 12 fetuses were included as controls without tracheoscopy 
after the target number of fetuses was reached for tracheoscopy. All fetuses undergoing 
tracheoscopy were injected with 1 mL (10/20) or 3 mL (10/20) of fluospheres. The fetoscopy 
duration per fetus was 12.9 ± 0.7 min. The tracheal diameter was 3.7 ± 0.7 mm as measured after 
harvesting; the total body weight 582 ± 112.7 g and the wet lung weight 19.0 ± 5.5 g. The average 
crown-to-rump length was 23.4 ± 1.7 cm and the distance between nose and larynx 6.8 ± 0.6 cm 
(Table 1). 
Determination of the optimal injection volume 
The efficacy of fluospheres distribution throughout the different lung lobes after injection of 1 and 3 
mL was evaluated by confocal microscopy (overview lung lobes, Fig. 3A). A representative image 
showing fluospheres delivery to the conducting airways and alveoli after 1 and 3 mL injection is 
depicted in Fig. 3B-E). Overall, the fluorescent intensity was higher for all lung lobes after injection of 
3 mL compared to 1 mL, except for the right caudal and right accessory lobe, where mean 
fluorescent intensity was comparable for both volumes (Fig. 3F). After injection of the high volume, 
more fluospheres were present in central and peripheral regions. The fluorescent intensity was 
higher in central than in peripheral regions for the 3 mL group, whereas equal amounts of 
fluospheres were distributed to both regions in the 1 mL group (Fig. 3G). A large variability was 
noted between the different animals injected in both groups (n=5/group), as well as a variable 
efficiency in targeting the different lobes (Fig. S1A,B). Part of this variability could be ascribed to 
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pleural effusion in the low volume group in 2/5 animals (Fig. S2), corresponding with low amounts of 
fluospheres present in the lung parenchyma throughout the lung. In contrast, no pleural effusion 
was observed in the high volume group, although 1/5 animals showed only a low amount of 
fluospheres throughout the lung (Fig. S1B). In conclusion, comparison of two injection volumes to 
target the fetal lung revealed that 3 mL resulted in the highest level of fluospheres present in the 
different lobes, as well as in a higher level of fluospheres in central lung regions. 
Analysis of procedure-related acute lung injury  
The acute lung injury score was determined for the different lung lobes (Supplementary table 1).  
No difference was observed between the different lobes and no significant differences were 
obtained between the different treatment groups which reached a score of 2.8 % ± 0.4 % for the 
negative control group, 2.8 % ± 0.6 % for the 1 mL fluosphere group and 2.7 % ± 0.6 % for the 3 mL 
fluosphere group. Highest scores were obtained for all groups in caudal lung segments. The lowest 
score was obtained in all groups in the right middle lobe. The results between groups (i.e. negative 
controls, 1 and 3 mL fluospheres) were not significantly different (p=0.870). In the acute trachea 
injury score the highest value reached in any category was 2/5 animals (Table 2). In rare cases, 
abnormal results were found for loss of epithelial integrity, loss of ciliated cells and altered pars 
membranacea, but there was no difference between the groups. In conclusion, based on the scoring 
system for both the parenchyma and trachea, no acute lung injury could be observed due to the 
fetoscopic procedure or the different volumes injected. 
Characterization of lung morphology and lung volumes by µCT  
A schematic overview of the monopodial porcine airway tree is given (Fig. 4A). The airway tiers 
(analogous to airway generations in a bipodal airway tree, cf. humans) are depicted. µCT allowed 
good visualization of the lungs up to the respiratory airways (Fig. 4B, Movie S1). On 10 µm resolution 
µCT, we analyzed two separate µCT samples of 1 cm in height and with a volume of 119.2 ± 2.2 mm3 
(Fig. 4B,C). The analyzed tracheal segment, close to the carina, had a diameter of 3.8 ± 0.2 mm and a 
volume of 9.2 ± 0.5 mm3. In lung tissue, we could identify 4 additional conducting airway tiers 
(trachea is annotated tier 0 29). These comprised an extra 1.9 ± 0.4 mm3. The conducting part of the 
airways thus has a volume of 11.1 ± 0.02 mm3. We subsequently analyzed the terminal bronchioles, 
as this region is thought to be important in the initial stages of lung pathology in CF patients 30 (Fig. 
4B-‘i’, Movie S1 arrows show where terminal bronchioles were calculated, i.e. at the transition point 
between conducting and respiratory airways). The terminal bronchioles had a diameter of 84.3 ± 
18.4 µm and cross-sectional area of 9604.2 ± 3090.2 µm2. 0.68 ± 0.02 terminal bronchioles per µL 
lung tissue were present. The tissue percentage of the lung was 69.4%, so 29.9 mm3 of lung tissue 
was made up of respiratory airways. The volume of the alveoli thus was 2.7 times higher than that of 
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the conducting airways (i.e. sum of tracheal segment and four conducting airway tiers). To estimate 
the total airway volume of the entire lung, the right lung was subsequently scanned at a resolution 
of 17.6 µm, resulting in 4.9 cm3 total lung volume. Based on our data found at high resolution, the 
volume of the respiratory airways in the right lung can thus was estimated at 1.2 mL and that of the 
conducting airways at 0.5 mL, which together comprise an estimated right lung airway volume of 1.7 
mL. As the right to left lung ratio was 1.38 ± 0.01 g (based on dry lung weights of three fetal lungs), 
total airway volume of both lungs could be estimated at 2.9 mL, which strengthens the observation 
that the highest volume of fluospheres (3 mL) resulted in widespread targeting of the different lobes 
(Fig. 3). 
Discussion 
In this manuscript we demonstrate that intratracheal fetoscopic application of nanoparticles in F90 
fetuses at hysterotomy, validated here by fluospheres, is possible in the pig. Fluospheres distribution 
was successful in all but one case at the beginning of our experience where a false route was taken 
(20/21 injected piglets). In the others, the intervention had no measureable acute effects on the 
fetuses or their lungs. We could identify most efficient nanoparticle delivery in all lung lobes after 3 
mL injection, however with notable variation between lung areas and in between animals. Based on 
high-resolution µCT, total airway volume was estimated at approximately 2.9 mL, strengthening that 
the 3 mL volume is appropriate to target all lung lobes.  
Different animal models have been described for intra-uterine nanoparticles delivery into fetal lungs 
17-21, 31, 32. Only larger animals, such as sheep, pig and primates allow the fetoscopic route due to their 
comparable anatomical size as humans. Fetoscopic application has the advantage that visual control 
allows correct airway delivery. We demonstrated that fetal tracheoscopy in pig is feasible and that 
injection of different volumes does not lead to measurable acute lung injury or tracheal damage. 
Additionally, local administration to the airways by direct intratracheal injection allows a lower dose 
to be administered compared to the technically easier intra-amniotic delivery, which is especially 
important in large animal models requiring large volumes injected. Compared to sheep and 
primates, pigs have the advantage having multigestational pregnancies of 8 to 12 piglets. Therefore 
more fetuses per sow can be used which reduces the number of animals needed for 
experimentation, as well as increases the number of internal littermate controls.  
We are aware of certain limitations in our study, one being the use of only two sows. However, our 
primary goal was to evaluate fetal tracheoscopic delivery, which we could apply in 21 fetuses. 
Thanks to the large litter size, we harvested another 12 controls. Another shortcoming is the short 
latency between operation and harvesting which was approximately 5-10 minutes. Again however, 
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our goal was to study the distribution of fluospheres following intratracheal delivery which 
inherently has to be studied as soon as possible after administration. On the other hand, studying 
the pharmacokinetics of the distributed nanoparticles is important as well, but this will depend 
strongly on the exact characteristics of the given nanoparticle. For example, viral vectors on average 
can enter a target cell in a short time frame (minutes-hours) 33, whereas for other nanoparticles such 
as stem cells it will be important that they can reside at the desired lung region for a longer time 
period (hours, days) 34. A next step towards the development of a preclinical animal model that 
allows long-term evaluation of the administered nanoparticle will require the development of an 
optimal surgical procedure that allows survival of the operated sow and piglets. In contrast to the 
present study, long-term experiments would necessitate the closure of the hysterotomy and 
laparotomy, which would lead to a considerably longer duration of surgery and potentially increase 
the risk of unsuccessful closure or wound healing complications. In general, pregnant sows are 
susceptible to stress-related abortion, that will have to be taken into account when optimizing the 
surgical procedure combining it with an optimal anesthesia protocol and minimal surgery duration 
35. To eventually translate fetal delivery experiments in WT pigs to gene therapy studies in the CF pig, 
toxicity and gene expression analyses will have to be optimized, assays already operational in sheep 
14, 15. However, many CF specific read-outs have recently been developed that allow assessment of 
the major hallmarks of CF airway disease in large animal models, such as mucociliary clearance, 
airway surface liquid depth and bacterial killing 13, 36, 37. Ultimately, combining all these read-outs will 
provide a complete overview of the safety and efficacy of novel therapies for CF. 
Another interesting point is whether fluosphere delivery is fully representative of predicting other 
nanoparticles’ biodistribution, as they might have different physicochemical properties. Fluosphere 
distribution depends on the particle size and the adhesion properties. For this study, we used 100 
nm anionic carboxylate-modified fluospheres, diluted 1:2 in saline, as they are superior for 
applications in biological systems. As they are highly charged, this reduces their attraction to 
negatively charged cell surfaces. Viral vector biodistribution depends on several factors, including 
vector size (e.g. 20 nm for rAAV), the substance it is dissolved in, usually saline, and its tropism. In 
the past we have already shown that the distribution of fluospheres was very comparable to that of 
rAAV2/6.2 delivery and subsequent gene expression in fetal mouse airways 16, 17. 
The delivery of two different fluospheres volumes (1 and 3 mL) allowed us to determine the optimal 
injection volume. Confocal analysis revealed that the high volume resulted in the highest level of 
fluospheres present in the different lung lobes. However, a large variability was noted between the 
different animals injected for both groups, as well as a variable efficiency in targeting the different 
lobes. In some of the animals with low amounts of fluospheres present in the lung parenchyma, 
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pleural effusion was noted. In none of the injected fetuses, spilling of fluospheres through the 
oropharynx was observed during administration. The 3 mL injection volume at first sight exceeds the 
total airway volume estimate of 2.9 mL. However, in this calculation only the distal trachea was 
included, whereas injection took place cranially to the tracheal bronchus. Therefore an excess of 
fluospheres was most likely not injected, even with the high volume. Additionally, lung fluid was 
aspirated prior to injection. Alternatively, leakage could have occurred due to procedural damage, 
i.e. placement of the fetoscope or the injected volumes. However, in the acute lung injury score no 
damage to trachea or parenchyma was evidenced, although small or local lesions could have been 
missed as the score is calculated on 5 high power fields per region per animal. We cannot exclude 
that leakage could have occurred while processing the whole lung into the different lung samples for 
microscopic analysis on frozen sections. This is something that will be taken into account in future 
experiments. Overall, 3 mL injection efficiently targeted the different lobes, suggesting this volume 
as appropriate for future administrations at this gestational age.  
These findings were strengthened by μCT where the total airway volume was estimated at 
approximately 2.9 mL based on detailed volume calculations of the conducting and respiratory 
airways combined with lower resolution µCT to determine the total lung dimension. Important to 
point out is that, to our knowledge, this is the first time a fetal pig lung is imaged by µCT. This 
pioneering comes with some intrinsic uncertainties. First, we found a high tissue percentage of 
69.4% compared to 30.6% air-filled space (expressed as fluid-filled space in a fetal setting). In human 
adult lung, the tissue percentage is approximately 20% based on µCT imaging using osmium as tissue 
contrast enhancement agent 38. This might be because of incomplete removal of liquid from the fetal 
lung or the inherent properties of the fetal lung at this specific lung developmental stage. The 
percentage of fluid-filled space measured by µCT ultimately impacts the airway volume calculations 
and errors at this stage will influence the value for the total airway volume, here estimated at 2.9 
mL. Also, there is no clear consensus on which terminology to use for labeling the different pig 
airways. Due to anatomical differences in branching pattern of human and pig conducting airways, 
i.e. a bipodal versus monopodial airway tree, the human nomenclature is not suited. In that light, 
Bauer and colleagues introduced a new terminology to more accurately label the porcine conducting 
airways 29. As an analog to human airway generations, they propose “airway tiers” (for a schematic 
overview see Fig. 4A). 
In conclusion, we demonstrated for the first time in a pregnant pig that intratracheal injection of 
nanoparticles is feasible via fetoscopy at hysterotomy. This delivery procedure to fetal airways opens 
up perspectives to further study the effect of nanoparticle delivery in a large fetal animal model. 
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Tables 
Table 1: Fetal macroscopic parameters 
GROUP Tracheal 
diameter 
(mm) 
Total body 
weight 
(g) 
Wet lung 
weight 
(g) 
Crown-to-
rump length 
 (cm) 
Nose-to-
larynx 
                    
(cm) 
Control 3,7 ± 0,7 544,9 ± 120,6 15,9 ± 3,3 22,8 ± 1,6 6,5 ± 0,6 
Fluospheres 
1 mL 
3,9 ± 0,6 605,8 ± 105,0 23,1 ± 5,9 23,7 ± 1,5 6,8 ± 0,5 
Fluospheres 
3 mL 
3,6 ± 0,6 602,7 ± 97,5 18,6 ± 4,5 23,7 ± 1,6 6,9 ± 0,5 
Fetal parameters were determined for 32 piglets (n=12 neg. controls; n=10 fluospheres 1 mL; n=10 fluospheres 
3 mL) at F90 after euthanasia and removal from the uterus. Macroscopic outcomes are reported for all fetuses 
and the calculated means ± s.d. given. 
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Table 2: Acute tracheal injury score 
GROUP aEpithelium  
integrity 
bEpithelium  
qualitative 
cEpithelium 
folding 
dSubmucosal 
reaction 
eCartilage 
viability 
fPars 
membranacea 
Control 1/5 2/5 0/5 0/5 0/5 1/5 
Fluospheres 
1 mL 1/5 1/5 0/5 0/5 0/5 1/5 
Fluospheres 
3 mL 1/5 1/5 0/5 0/5 0/5 1/5 
The numbers shown are positive cases (n) of total cases per treatment group (5). The influence of intratracheal 
injection on the tracheal tissue was evaluated as in 
27
. Explanation of the different outcomes: 
a
Epithelium 
integrity: 0 = Intact, 1 = defect; 
b
Epithelium qualitative: 0 = normal ciliary epithelium, 1 = Squamous 
metaplasia; 
c
Epithelium folding : 0 = normal folding, 1 = unfolding or compression; 
d
Submucosal acute 
inflammatory reaction: 0 = absent, 1 = infiltration of neutrophils; 
e
Cartilage viability: 0 = normal, 1 = cartilage 
destruction or deformity; 
f
Pars membranacea: 0 = normal, 1 = intramural/transmural rupture of muscle. 
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